Getting a GLP-1 prescription online in 2026 is straightforward — if you know what to expect. Telehealth platforms have streamlined the process to the point where most patients can go from initial consultation to medication delivery in under a week. Here's exactly how it works, step by step.
Who Qualifies for a GLP-1 Prescription?
GLP-1 medications are prescribed for two primary indications: type 2 diabetes management and chronic weight management. For weight loss specifically, the FDA-approved criteria require either a BMI of 30 or above (obesity), or a BMI of 27 or above with at least one weight-related health condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea.
Most telehealth providers use these same criteria. Some compounding-focused platforms may have slightly broader qualifying standards, but a BMI of 27+ with comorbidities is the practical threshold across the board.
Step 1: Choose Your Provider Type
The first decision is what type of provider — and what type of medication — you want. This determines your pricing, the prescribing process, and what you'll actually receive.
| Provider Type | Medication | Typical Cost | Best For |
|---|---|---|---|
| Telehealth + compounded | Compounded semaglutide or tirzepatide | $130–$300/mo | Cost savings, cash-pay patients |
| Telehealth + brand-name | FDA-approved Wegovy, Zepbound, Ozempic | $300–$1,350/mo | Patients wanting exact FDA-approved products |
| Primary care physician | Any FDA-approved GLP-1 | Insurance copay or retail | Patients with insurance coverage |
If cost is your primary concern and you're paying out of pocket, compounded options through telehealth providers typically save $500–$1,000+ per month compared to brand-name retail pricing.
Step 2: Complete the Online Consultation
Most telehealth GLP-1 providers use an asynchronous questionnaire model — meaning you answer health questions online, and a licensed provider reviews your information without a live video call. Some platforms do offer optional video consultations.
Expect to provide:
- Height, weight, and BMI (most platforms calculate this for you)
- Medical history, including current medications and allergies
- Previous weight loss attempts and current health conditions
- Blood pressure readings (some providers require this; others don't)
- Goals for treatment — weight loss, blood sugar management, or both
The questionnaire typically takes 5–10 minutes. Provider review usually happens within 24–48 hours, though some platforms offer same-day review.
Step 3: Provider Review and Prescription
A licensed prescriber (MD, DO, NP, or PA depending on the platform and state) reviews your questionnaire and medical history. If you qualify, they write a prescription for the appropriate GLP-1 medication and dosage.
Starting doses are standardized across all providers: semaglutide begins at 0.25mg weekly for the first four weeks, then titrates upward. Tirzepatide starts at 2.5mg weekly. This titration schedule is non-negotiable — it's built into the prescribing guidelines to minimize side effects.
If you don't qualify, the provider will explain why. Common disqualifiers include a history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, active pancreatitis, or pregnancy.
Step 4: Medication Delivery
Once prescribed, your medication ships directly to your home. Most compounded medications arrive within 3–7 business days. Brand-name prescriptions may be sent to a retail pharmacy for pickup, or shipped directly depending on the platform.
Compounded injectable medications arrive as vials with syringes. Brand-name products come as pre-filled injection pens. Both include dosing instructions.
Step 5: Ongoing Management
GLP-1 therapy is not a one-time prescription. You'll need ongoing check-ins with your provider for dose titration (increasing the dose every 4 weeks as tolerated), side effect management, and progress monitoring. Most telehealth platforms build this into their monthly subscription.
Top Online Providers Accepting Patients Now
SkinnyRx
BB Health+
Oak Longevity
Wellorithm
Care Bare Rx
Regulatory Note: May 2026
The FDA proposed removing semaglutide, tirzepatide, and liraglutide from the drug shortage bulks list on April 30, 2026. A public comment period runs through June 29, 2026. If finalized, this could limit compounding pharmacies' ability to produce these medications. Patients considering compounded options should be aware of this timeline.
Compare all online GLP-1 prescription providers
See Full Comparison →Sources
- FDA prescribing information for Wegovy (semaglutide) and Zepbound (tirzepatide): BMI criteria, contraindications, and titration schedules.
- FDA Drug Shortage Bulks List Proposal — April 30, 2026. Federal Register notice with public comment period through June 29, 2026.
- 503A and 503B compounding pharmacy regulations — FDA Compounding Quality Center.
- Provider pricing and program details verified via provider websites, May 2026.
Affiliate Disclosure: Some links on this page are affiliate links and may generate compensation. This does not influence our editorial content or recommendations.